Harbin Medical University

• NCT07682376

  Phase 2, Active, not recruiting, 96 people, 2 Jul 2026

• NCT06648525

  Phase 2, Not yet recruiting, 68 people, 18 Oct 2024

• NCT06306560

  Phase 2, Not yet recruiting, 40 people, 12 Mar 2024

• NCT06196697

  Phase 2, Recruiting, 50 people, 9 Jan 2024

• NCT05076786

  Collaborator, Phase 2, Status unknown, 28 people, 13 Oct 2021

• NCT04807673

  Collaborator, Phase 3, Recruiting, 342 people, 19 Mar 2021

• NCT03351062

  Collaborator, Phase 3, Status unknown, 844 people, 22 Nov 2017

• NCT02672488

  Collaborator, Phase 2, Status unknown, 82 people, 3 Feb 2016

• NCT02484911

  Collaborator, Phase 3, Completed, 120 people, 30 Jun 2015

• NCT01798251

  Phase 2, Status unknown, 40 people, 25 Feb 2013

• NCT01665274

  Phase 2, Terminated, 15 people, 15 Aug 2012

• NCT01053390

  Collaborator, Phase 3, Completed, 216 people, 21 Jan 2010

• NCT01023607

  Phase 4, Completed, 120 people, 2 Dec 2009

• NCT00520247

  Collaborator, Phase 2, Completed, 443 people, 23 Aug 2007

• Cost-effectiveness of an integrated falls prevention programme in primary healthcare for older people in rural China: an economic evaluation alongside the FAMILY trial

  31021220002, 4 Sept 2026

• Artesunate reverses BMSC senescence and ameliorates osteoporosis by upregulating NSD2

  2024YQ20, 2025M16, 5 Dec 2025

• O304 is a mitochondrial uncoupler which extends C. elegans lifespan and induces vasorelaxation of rat mesenteric arteries

  HDHY2024003, 21 Oct 2025

Sources: api.crossref.org

• The relationship between ions exposure and incident stroke with different severity and its mediating effect analysis

  Fees or honoraria, 17 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov